Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

1081 - 1090 of 3833 results found

EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia

MeSH Terms

Creatine Kinase / blood*

Female

Humans

Muscular Diseases / blood*

Muscular Diseases / diagnosis*

Muscular Diseases / enzymology

Reference Values

Guideline Contact
Dr T. Kyriakides, Clinical Neurosciences, The Cyprus Institute of Neurology and Genetics, 6, International Airport Av., 2370 Nicosia, Cyprus (tel.: 0035722392758; fax: 0035722392786; e-mail: [email protected])
Publication Date
13 May 2010
Date of Last Evidence Search
7/7/2009
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Diagnosis
Humans
Assessment, diagnosis, detection
Assessment, diagnosis, investigation
Diagnosis
Diagnostics
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
7
Willingness to Collaborate
Yes

EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias

MeSH Terms

Ataxia / diagnosis*

Ataxia / genetics*

Ataxia / metabolism

Humans

Paraplegia / diagnosis

Paraplegia / genetics

Paraplegia / metabolism

Spastic Paraplegia, Hereditary / diagnosis*

Spastic Paraplegia, Hereditary / genetics*

Spastic Paraplegia, Hereditary / metabolism

Guideline Contact
T. Gasser, Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Otfried-Müller-Str. 27, 72076 Tübingen, Germany (tel.: +49 70 712 986529; fax: +49 70 712 94839; e-mail: [email protected]).
Publication Date
13 January 2010
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Diagnosis
Humans
Assessment, diagnosis, detection
Assessment, diagnosis, investigation
Detection
Diagnosis
Diagnostics
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
18
Willingness to Collaborate
Yes

EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias

MeSH Terms

Channelopathies / diagnosis*

Channelopathies / epidemiology

Channelopathies / genetics

Dementia / diagnosis*

Dementia / epidemiology

Dementia / genetics

Epilepsy / diagnosis*

Epilepsy / epidemiology

Epilepsy / genetics

Europe / epidemiology

Evidence-Based Medicine

Humans

Infant, Newborn

Migraine Disorders / diagnosis*

Migraine Disorders / epidemiology

Migraine Disorders / genetics

Molecular Biology / methods

Molecular Biology / standards*

Molecular Biology / trends

Molecular Diagnostic Techniques / methods*

Molecular Diagnostic Techniques / standards*

Molecular Diagnostic Techniques / trends

Societies, Medical / standards

Societies, Medical / trends

Stroke / diagnosis*

Stroke / epidemiology

Stroke / genetics

Guideline Contact
J.-M. Burgunder MD, Department of Neurology, University of Bern, Inselspital, CH-3010 Bern, Switzerland (tel.: +41313522070; fax: +41313518070; e-mail: [email protected]
Publication Date
12 April 2010
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Diagnosis
Humans
Investigation
assessment
Assessment, diagnosis, detection
Assessment, diagnosis, investigation
Detection
Diagnosis
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
18
Willingness to Collaborate
Yes

EFNS guidelines on the molecular diagnosis of mitochondrial disorders

MeSH Terms

Humans

Mitochondrial Diseases / diagnosis*

Mitochondrial Diseases / genetics*

Molecular Biology / methods*

Guideline Contact
J. Finsterer, Postfach 20, 1180 Vienna, Austria (tel.: +43 1 71165 92085; fax: +43 1 4781711; e-mail: [email protected])
Publication Date
17 November 2009
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Diagnosis
Humans
Assessment, diagnosis, detection
Assessment, diagnosis, investigation
Detection
Diagnosis
Diagnostics
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
18
Willingness to Collaborate
Yes

EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington’s disease, Parkinson’s disease and dystonias

MeSH Terms

Databases, Bibliographic / statistics & numerical data

Dystonia / diagnosis*

Dystonia / genetics

Genetic Counseling / methods

Guidelines as Topic / standards*

Humans

Huntington Disease / diagnosis*

Huntington Disease / genetics

Molecular Diagnostic Techniques / methods*

Parkinson Disease / diagnosis*

Parkinson Disease / genetics

Guideline Contact
Hanne F. Harbo, MD, PhD. Department of Neurology, Ullevål, Oslo University Hospital, 0407 Oslo, Norway (tel.: +47 22118636/+47 99546680; fax: +47 23027455; e-mail: [email protected]/[email protected])
Publication Date
03 June 2009
Date of Last Evidence Search
Evidence classification; Experts' recommendations
Publication Scope
Diagnosis
Humans
Investigation
Assessment, diagnosis, detection
Assessment, diagnosis, investigation
Detection
Diagnosis
Diagnostics
Management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
18
Willingness to Collaborate
Yes

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

MeSH Terms

Amines / therapeutic use

Analgesia / trends*

Analgesics / therapeutic use*

Analgesics, Opioid / therapeutic use

Antidepressive Agents, Tricyclic / therapeutic use

Cyclohexanecarboxylic Acids / therapeutic use

Drug Therapy, Combination / trends

Europe

Gabapentin

Humans

Neuralgia / classification

Neuralgia / drug therapy*

Outcome Assessment, Health Care / trends

Peripheral Nervous System Diseases / classification

Peripheral Nervous System Diseases / drug therapy*

Randomized Controlled Trials as Topic / trends

Treatment Outcome

gamma-Aminobutyric Acid / therapeutic use

Guideline Contact
N. Attal, INSERM U 987, Centre d’Evaluation et de Traitement de la Douleur, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France (tel.: +0033149095946; fax: 0033149094435; e-mail: [email protected])
Publication Date
07 April 2010
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Humans
Management
Management: Treatment
Neuralgia / therapy
Treatment
Pain Management
treatment
Treatment, management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
7
Willingness to Collaborate
Yes

EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases

MeSH Terms

Family

Humans

Magnetic Resonance Imaging / methods*

Motor Neuron Disease / diagnosis*

Motor Neuron Disease / metabolism

Motor Neuron Disease / pathology*

Motor Neuron Disease / therapy

Positron-Emission Tomography / methods*

Guideline Contact
Massimo Filippi, Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, Scientific Institute and University Hospital San Raffaele, Via Olgettina, 60, 20132 Milan, Italy (tel.: +39 02 26433033; fax: +39 02 26435972; e-mail: [email protected])
Publication Date
15 March 2010
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Humans
Magnetic Resonance Imaging /
Management
Assessment, management
Diagnosis-Management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
10
Willingness to Collaborate
Yes

EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis

MeSH Terms

Brain / pathology*
Humans
Magnetic Resonance Imaging*
Multiple Sclerosis / diagnosis*
 

Guideline Contact
M. Filippi, Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University Ospedale San Raffaele, Via Olgettina 60, 20132 Milan, Italy (tel.: 39-02-26433032; fax: 39-02-26433054; e-mail: [email protected]).
Publication Date
21 April 2006
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Humans
Magnetic Resonance Imaging /
Management
Assessment, management
Diagnosis-Management
Management
Management, assessment, investigation
monitoring
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
9
Willingness to Collaborate
Yes

EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy

MeSH Terms

Biopsy / methods
Biopsy / standards*
Diagnostic Techniques, Neurological
Health Planning Guidelines
Humans
Immunohistochemistry / methods
Nerve Fibers / metabolism
Nerve Fibers / physiology
Peripheral Nervous System Diseases / diagnosis*
Peripheral Nervous System Diseases / physiopathology
Skin / pathology*

Guideline Contact
Giuseppe Lauria, MD, Immunology and Muscular Pathology Unit, National Neurological Institute ‘Carlo Besta’, Via Celoria, 11, 20133 Milan, Italy (tel.: +39 02 2394 2255; fax: +39 02 7063 3874; e-mail: [email protected])
Publication Date
27 September 2005
Date of Last Evidence Search
31 March 2005
Methods Applied
Evidence classification; Experts' recommendations
Publication Scope
Diagnosis
Humans
assessment
Assessment, diagnosis, detection
Assessment, diagnosis, investigation
Detection
Diagnosis
Management
Treatment, management
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
8
Willingness to Collaborate
Yes

EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy

MeSH Terms

Age Factors

Biopsy / standards*

Female

Humans

Male

Peripheral Nervous System Diseases / pathology*

Practice Guidelines as Topic

Sex Characteristics

Skin / innervation*

Skin / pathology

Guideline Contact
Dr Sung-Tsang Hsieh, PhD, MD, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei 100, Taiwan (tel.: +886 2 23123456 (x 8182); fax: +886 2 23915292; e-mail: [email protected])
Publication Date
13 November 2006
Methods Applied
Expert's comment
Publication Scope
Diagnosis
Humans
Assessment, diagnosis, detection
Assessment, diagnosis, investigation
Detection
Diagnosis
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Willingness to Collaborate
Yes